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Abstract
Background: Previous reports suggest that beneficial effects of soy on bone quality are due to the estrogenic actions of
isoflavone phytochemicals associated with the protein. However, mechanistic studies comparing the effects of soy diet and
estrogens on bone, particularly in rapidly growing animals are lacking.
Methodology and Principal Findings: We studied the effects of short term feeding of soy protein isolate (SPI) on bone in
comparison to the effects of 17b-estradiol (E2) in pre-pubertal rats. Female rats were weaned to one of 4 treatments: 1) a
control casein-based diet (CAS); 2) CAS with subcutaneous E2 (10 mg/kg/d) (CAS+E2); 3) a SPI-containing diet (SPI); or 4) SPI
with subcutaneous E2 (SPI) or SPI with 10 mg/kg/d E2 (SPI+E2) for 14 days beginning on postnatal day 20. SPI increased
while E2 decreased bone turnover compared to CAS. In contrast, both treatments decreased serum sclerostin levels.
Microarray analysis of RNA isolated from bone revealed 652 genes regulated by SPI, 491 genes regulated by E2, and 266
genes regulated by both SPI diet and E2 compared to CAS. The expression of caveolin-1, a protein localized in the cell
membrane, was down-regulated (p,0.05) in rats fed SPI, but not by E2 compared to rats fed casein. Down-regulation of
caveolin-1 by SPI was associated with increased BMP2, Smad and Runx2 expression in bone and osteoblasts (p,0.05).
Conclusions/Significance: These results suggest SPI and E2 have different effects on bone turnover prior to puberty.
Approximately half of the genes are regulated in the same direction by E2 or SPI, but in combination, SPI blocks the
estrogen effects and returns the profile towards control levels. In addition, there are E2 specific and SPI-specific gene
changes related to regulation of bone formation.
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Introduction
Although beneficial skeletal effects of soy-containing diets have
been suggested for decades [1], this is a controversial area. In
addition, the mechanisms of potential soy effects on bone remain
unclear, but most reports suggest that soy phytochemicals
(isoflavone phytoestrogens, such as genistein and daidzein) are
responsible. Isoflavones are structurally similar to 17b-estradiol
and are estrogenic under certain physiological conditions [2].
Therefore, soy has been used by some postmenopausal women as
a natural alternative to estrogen replacement therapy [3]. More
recently, evidence suggests that isoflavones may not only have
estrogenic effects, but are also antiestrogenic in some mammalian
tissues [4]. The preferential binding of isoflavones to estrogen
receptor b suggests that they may act as SERMs (selective estrogen
receptor modulators) [5]. The majority of soy diet and bone
research has been conducted in adult human participants and
experimental rodents. However, unlike in some Asian countries
where soy diets are constantly consumed by every age group in the
population, in the USA, soy-containing food is mainly consumed
by infants in the form of soy infant formula [6]. Assessing the
effects of soy consumption early in life on estrogen sensitive organs
has become a high research priority as the result of safety concerns
with regards to potential toxic effects on reproductive development
and increased cancer risk [7,8]. We and others have started to
examine the effects of soy foods consumed in early life and
evaluated its consequences on bone health later in adult life [9,10].
We hypothesized that dietary factors other than isoflavones
appearing in serum after feeding soy diets may also have effects
on bone formation. The relative concentrations and forms of
dietary factors associated with soy diets are significantly affected by
PLoS ONE | www.plosone.org 1 April 2012 | Volume 7 | Issue 4 | e35736processing of soy beans into different products, and may be species
and age dependent [11].
Human peak bone mass is usually reached in the late third
decade of life. This bone mass or mineral density in adults reflects
the extent of bone acquisition during growth and affects the
subsequent rate of bone loss [12]. More than half of adult bone
mass is made under the influence of growth hormone from the
anterior pituitary gland and sex hormones during the peri-pubertal
period [13]. Appropriate bone modeling during the peri-pubertal
period may be essential to determine whether an individual is at
higher or lower risk for bone fracture later in adult life [14].
Although the exact mechanisms and differences between males
and females are not well understood, estrogen interacting with
growth hormones is absolutely critical in both sexes for building
bone strength and increasing long bone length. In rodents, such as
rats, bone growth from weaning to postnatal day 35 is rapid and is
under the control of a variety of hormones and cytokines. Bone
mass acquisition during this time is similar to conditions which
occur in pre-pubertal humans. Whether soy phytochemicals
interact with the endogenous factors to determine: bone structure;
bone turnover; and homeostasis of calcium, phosphorus and
vitamin D during the pre-pubertal period are not well understood.
It is well known that the actions of estrogen in a variety of tissues
and cells are primarily through estrogen receptors alpha (ERa)
and beta (ERb). While these receptors have overlapping
responsibilities, they also have distinct roles in different tissue
and cell types [15]. It has been established that one of the effects of
estrogen on bone cells is through classic activation of ERa in the
nucleus to transcribe estrogen-responsive genes. In contrast to this
classic estrogen signaling in bone cells, previous studies suggest
that a membrane ER complex may also activate cytoplasmic
kinases to transmit non-genomic actions of estrogens [16].
Interestingly, soy consumption has been shown to activate
cytoplasmic kinases such as ERK and Smad(s) in bone in vivo,
which are requirements for osteoblast differentiation/osteoblasto-
genesis [9]. We have previously hypothesized that the effects of soy
diet on bone may be largely due to non-estrogenic actions [17].
The purpose of the present study was to compare the short term
effects of consumption of a soy diet relative to 17b-estradiol on
bone turnover in prepubertal intact female rats. In addition,
studies were conducted to investigate signaling transduction to
determine whether the effects of SPI (soy protein isolate) feeding
on bone cells are different from classical actions of estrogens.
Results
Effects of SPI and E2 treatment on serum isoflavone and
E2 concentrations
Measurement of serum isoflavone values after feeding SPI
confirmed previous data from rats in our laboratory (Table 1) [18].
Total isoflavone concentrations were in the range of 1 mM and the
major isoflavone was the most estrogenic daidzein metabolite
equol (Table 1). In addition, more than ninety percent of
isoflavones were found in the conjugated form and free aglycone
values were less than 40 nM. E2 treatments increased mean serum
E2 concentrations from 2563 pM in controls to 7166 pM in the
10 mg/kg/d group. Addition of SPI had no significant effect (by t-
test) on serum E2 values either when fed alone (3666 pM SPI vs
2563 pM CAS) or when fed in combination with 10 mg/kg/d E2
(7166 pM, CAS+10 mg/kg/d E2 vs 91614, SPI+10 mg/kg/d
E2).
Effects of SPI and E2 on Bone Turnover in Prepubertal
Rats
Bone turnover markers were measured in rat serum using
ELISA. The bone resorption marker RatLap and bone formation
markers ALP and osteocalcin were lower (p,0.05) in the CAS+E2
group compared to CAS, the bone resorption marker RatLap and
bone formation markers ALP and osteocalcin were all higher in
SPI compared to CAS groups (p,0.05, Figure 1A–C). Interest-
ingly, circulating levels of sclerostin were lower in both SPI and
CAS+E2 groups compared to CAS (p,0.05, Figure 1D).
Changes in gene expression in bone in response to SPI
and E2
To identify the target genes in bone interacting with SPI or E2
that result in their different effects on bone, we analyzed mRNA
from long bone using Affymetrix gene arrays. These analyses
revealed 652 genes regulated more than 1.5-fold by SPI diet, 491
genes regulated by 10 mg/kg/d of E2 and only 133 genes
regulated by SPI plus E2 compared with their expression in the
CAS group (Figure 2A). Of these genes, 266 genes, (about 50%)
were regulated in a similar fashion by both the SPI diet and E2
treatment in these prepubertal rats compared to casein. However,
this decreased to 24 genes when the SPI+E2 group was compared
to CAS (Figure 2A).
More detailed microarray data analysis for these genes showed
different patterns of gene regulation by SPI, E2 and SPI+E2
(Figure 2B). The top twenty-five up-regulated genes, and all down-
regulated genes by either SPI or E2 are shown in Figure 2C and
2D respectively. Interestingly, the major SPI up-regulated genes
were also up-regulated by E2, but less robustly. For example,
Snap25 (Synaptosomal-associated protein 25), a known molecule
expressed on osteoblastic cells [19] was up-regulated by both SPI
and E2. The SPI down-regulated genes were also down-regulated
by E2. However, many E2 down-regulated genes were up-
regulated by SPI-feeding. Strikingly, the combination of E2
treatment and SPI feeding antagonized most of the gene changes
produced by either treatment alone. The detailed data has been
deposited in a MIAME compliant database (E.g. ArrayExpress,
GEO), and it is available to check on the MGED Society website
with accession number GSE30862 http://www.ncbi.nlm.nih.gov/
geo/query/acc.cgi?acc=GSE30862.
Table 1. Serum isoflavone concentration.
Serum isoflavone levels (nM)
Control SPI
Free Total Free Total
DHD nd nd 1.260.19 140.1626.2
Glycetein nd nd 9.560.7 60.064.9
Genistein nd nd 38.269.6 921.8680.7
Daidzein nd nd 37.468.7 521.6650.8
o-DMA nd nd 5.460.31 767.4688.8
Equol nd nd 15.762.5 2207.46193.8
Serum isoflavones were measured using LC-MS method.
nd, non detected. DHD, dihydrodaidzein. o-DMA, o-desmethylangolansin.
doi:10.1371/journal.pone.0035736.t001
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of mRNA encoding caveolin-1, a protein localized in the cell
membrane, was down-regulated in rats fed SPI (2.8-fold), but not
by E2 compared to CAS. This was confirmed by a real-time PCR
analysis (p,0.05, Figure 3). On the other hand, expression of
ATF-3 mRNA (activating transcription factor 3) known as a
regulator of endochondral bone growth and skeletal development
was only significantly up-regulated by E2 (both array and real-time
PCR data ) and SPI did not block this effect (Figure 3). Calcitonin
(calcitonin gene-related peptide) was up-regulated by both E2 and
SPI (Figure 3) (both array and real-time PCR revealed) but to a
much greater level by SPI than E2. Moreover, real-time PCR
analysis showed decreases in mRNA expression of Sost (the gene
encoding sclerostin) in bone after E2 or SPI treatment coincident
with with decreases in the serum level of sclerostin presented in
Figure 1 (Figure 3). Proteins were isolated from bone, and Western
blots were performed. We found that down-regulation of caveolin-
1 by SPI was associated with increased expression of BMP-2 (bone
morphogenetic protein -2), particularly cytosolic BMP-2 expres-
sion (Figure 4). E2 treatment did not down-regulate caveolin-1,
but increased cytosolic expression of BMP-2 compared to CAS
(p,0.05), indicating E2 activates BMP-2 by mechanisms different
than SPI.
Both SPI and E2 increased BMP-2 and Runx2 but as a
result of different molecular signaling pathways
It is known that the BMP-2 signaling cascade represents one of
the most potent stimuli for bone formation. In order to determine
cell signaling transduction after activation of BMP-2 by SPI, we
isolated protein from bone after aspiration of bone marrow cells
and performed Western blots. p-Smad 1/5/8, Runx2 and p-ERK
were increased by both SPI and E2 treatment compared to the
CAS group (p,0.05, Figure 5A). While real-time PCR analyses
also showed significant up-regulation of Runx2 mRNA, the up-
regulation by SPI was less than by E2 treatment or SPI plus E2
(p,0.05) (Figure 5B). Finally, we used an in vitro ST2 cell culture
model to examine the differences between E2 and SPI on initiating
osteoblastic cell differentiation signals. Cells were treated with 2%
serum either from CAS control diet, 10 mg/kg/d E2 or SPI diet
rats or with 5 mM of purified genistein for 48 h, RNA and protein
were collected. Real-time PCR and Western blot analyses revealed
that caveolin-1 was down-regulated (p,0.05) only by serum from
SPI rats at both the mRNA and protein level (Figure 6). Down-
regulated caveolin-1 was associated with increased cytosolic but
decreased membrane expression of BMP-2 (Figure 6). Although
serum from the 10 mg/kg/d E2 group and genistein both up-
regulated Runx2 (mRNA) and BMP-2 (protein) expression,
neither one regulated caveolin-1 at either the mRNA or protein
levels (Figure 6). These findings demonstrate for the first time that
SPI, genistein and E2 may all have some abilities to stimulate
osteoblast differentiation, but the triggers of the signaling pathway
are different.
Discussion
Soy foods have been reported to have a variety of health
benefits including prevention of cardiovascular disease and
amelioration of bone loss in some clinical studies and animal
models of osteoporosis [20]. At least one explanation for these
beneficial effects is that soy foods contain weak estrogenic
compounds – the isoflavones genistein and daidzein. However,
the underlying mechanisms of soy diet or of purified isoflavones on
bone and whether these effects are life stage-dependent remain
Figure 1. Changes in bone resorption and formation markers in pre-pubertal rats. (A) Serum bone formation markers ALP (bone specific
alkaline phosphatase) and (B) osteocalcin, and (D) serum level of sclerostin were measured by ELISA. (C) Bone resorption marker RatLap (C
telopeptide of type 1 collagen) was measured using a CrossLaps ELISA kit. Control, standard casein diet group; E2, 10 mg/kg/d E2 treated group; SPI,
soy protein isolate diet group; E2+SPI, combination of 10 mg/kg/d E2 treated and SPI diet group. Means 6 S.E.M with different letters differ
significantly from each other at p,0.05, a,b,c.
doi:10.1371/journal.pone.0035736.g001
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showed that purified genistein has a very minor effect on bone
added more controversy regarding the effects of soy diet on bone
in the older population [21]. The results reported in our current
study suggest that the effect of short term of SPI diet in pre-
pubertal female rats on bone differed from that of classical
estrogens. This SPI effect is consistent with our previously
published data on rats and pigs [9,17]. The effect of E2 on bone
from our current study in pre-pubertal rats is also consistent with
recent studies [22]. It is well known that estrogens have ability to
suppress osteoclastic bone resorption leading to decreased bone
remodeling and increased bone mass and strength. This bone
remodeling suppressive effect of E2 was used for its clinical
application on sex steroid deficiency-induced bone loss, because
the hallmark of sex steroid deficiency-triggered bone loss is a high
bone turnover. Compared with E2, bone turnover markers and
microarray data indicated that the effect of soy diet on bone has
some commonalities with E2. For example, they both decreased
circulating levels of sclerostin and share regulation of some genes.
However, the overall effect of the two treatments is decidedly
different. Interestingly, the bone turnover data in SPI+E2 rats
showed intermediary effects between SPI and E2 alone. The SPI
and E2 combination group did not show additive effect of SPI on
E2. This is consistent with our array data suggesting SPI and E2
may have mutually antagonistic effects on bone.
Relative to 17b-estradiol, serum isoflavone aglycone concentra-
tions in SPI-fed rats are approximately 2200 times greater.
However, because the potency of isoflavones is much lower than
estradiol, estrogenic effects of isoflavones in soy diets on bone may
be minimal or even antagonistic in the face of endogenous levels of
estrogens. Therefore, the bone effects of soy diets may depend on
developmental stage and endogenous E2 levels.
Consistent with our in vivo data, when we treated uncommitted
osteoblast progenitors with serum from E2- or SPI-treated
animals, we found that serum from SPI rats significantly down-
regulated caveolin-1 at both the mRNA and protein levels. In
sharp contrast, both E2 and genistein did not down-regulate
caveolin-1. These data combined with the gene expression data
suggest that a dietary factor(s) other than isoflavones appearing in
serum after consumption of soy diets acts on caveolin-1 expression
Figure 2. Microarray analysis shows differential signatures of SPI, E2, and SPI+E2 on gene expression in bone in pre-pubertal
female rats. (A) Venn diagrams on the differentially expressed genes among groups. (B) Different pattern of gene regulation by SPI, E2 and SPI+E2
from 266 genes showed in (A). (C) Top 25 genes up-regulated by SPI and all genes down-regulated by SPI from 266 genes. (D) Top 25 genes up-
regulated by E2 and all genes down-regulated by E2 from 266 genes showed in (B).
doi:10.1371/journal.pone.0035736.g002
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increased trabecular bone is one of the phenotypes in caveolin-1
deletion mice [23]. Caveolin-1 is a scaffolding protein containing a
33 amino acid hydrophobic domain that anchors the protein to
the membrane [24]. Such proteins include bone morphogenetic
proteins (BMP). Our in vivo data support the hypothesis that down-
regulation of caveolin-1 triggers release of BMP-2 from the
membrane, activating associated kinases in the cytoplasm. These
data suggest that the effect of soy diets on osteoblastogenesis is
largely due to actions via BMP signaling. On the other hand,
BMPs also activate intracellular transcription factors Smad-1, -5
and -8 (Smad-1/5/8) and proceed toward dimerization with
Smad-4 (Co-Smad, common Smad) before translocation into the
nucleus [25]. Nuclear translocated Smad complexes then regulate
bone specific gene transcription. BMPs have also been reported to
stimulate MAP kinase, supporting the idea that Smad-independent
signals may be required for the maximum activation of BMP
signals in osteoblasts [26]. All of those above mentioned BMP-
associated transduction molecules, as well as Runx2, an absolute
osteoblast differentiation transcription factor, were activated in
bone tissue from SPI-fed animal in vivo. These results suggest novel
actions of soy diet on bone development. E2 shares part of the
described signaling, however, it did not initiate activation of
caveolin-1 and thus may act through activation of its own
receptors, estrogen receptor alpha or beta.
In summary, we have utilized pre-pubertal female rats as a
model and demonstrated distinct effects of E2 and SPI diet on
bone even though both treatments seem to share some pathways.
E2 plus SPI had no additive effects on bone but rather the two
treatments cancelled each other out suggesting negative cross talk
between SPI-regulated and E2-regulated pathways. Consumption
of the SPI diet down-regulated the expression of caveolin-1, and
was associated with increased cytosolic BMP2, and Smad and
Runx2 expression in bone and osteoblasts. These results suggest
that SPI consumption results in significant stimulation of
osteoblastogenesis prior to puberty, and initiation of osteogenic
signals may differ than estrogen at this developmental stage.
Materials and Methods
Animal Experiments
Time-impregnated female Sprague-Dawley rats (Harlan Indus-
tries, Indianapolis, IN) arrived on gestational day 4 and were
individually housed in an Association for Assessment and
Accreditation of Laboratory Animal Care-approved animal facility
at the Arkansas Children’s Hospital Research Institute with
constant humidity and lights on from 06:00–18:00 hrs at 22uC. All
animal procedures were approved by the Institutional Animal
Care and Use Committee at University of Arkansas for Medical
Sciences (UAMS). The approval ID for this study is 2473.
Pregnant rats were fed AIN-93G diets made with casein as the sole
protein source [27] and their female offspring weaned at postnatal
day 20 (PND20) onto one of the following diets: AIN-93G diets
with casein (CAS) or made with soy protein isolate (SPI). The diets
were made to be isonitrogenous and isocaloric. The calcium and
phosphorus levels were adjusted to be the same in each diet. Diets
were made according to the AIN-93G diet formula, and the
protein source was either casein (Fonterra, Santa Rosa, CA) or SPI
(Clinical blend 670, a gift from Solae, Du Pont, St. Louis, MO).
The percentage of protein content of each diet was 20%. Amino
Figure 3. Real-time PCR verification of expression of genes of caveolin-1, ATF-3, calcitonin and Sost (sclerostin) in bone. Black bars
represent fold changes with microarray analyses and gray bars represent relative mRNA expression from real-time PCR analyses. Control, standard
casein diet group; E2, 10 mg/kg/d E2 treated group; SPI, soy protein isolate diet group; E2+SPI, combination of 10 mg/kg/d E2 treated and SPI diet
group. Means 6 S.E.M of real-time PCR results with different letters differ significantly from each other at p,0.05, a,b,c,d.
doi:10.1371/journal.pone.0035736.g003
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among diets. The detailed composition of the SPI diet was fully
described in our lab previously [28]. Two groups of rats received
E2 administered by Alzet mini osmotic pump (model # 2004,
AlzaCorp., CA) implanted subcutaneously. The dose was 10 mg/
kg/day of E2. After 14 d of ad libitum feeding, the rats were
sacrificed 1 hour following lights-on by injection with 100 mg
Nembutol/kg body weight (Avent Laboratories), followed by
decapitation. Blood and bone (tibia) were collected.
Serum Bone Turnover Markers and Isoflavones
The serum bone formation marker alkaline phosphatase (ALP)
was measured by a colorimetric assay using the time-dependent
formation of p-nitrophenolate from para-nitrophenyl phosphate
(PNPP). The protocol used 5 ml of serum in a total volume of
1.5 ml containing 0.05 mmol/L PNPP, 2 mmol/L MgCl2, and
10 mmol/L L-phenylalanine (to inhibit any circulating intestinal
ALP activity). The serum bone formation marker osteocalcin and
the serum bone resorption marker RatLaps (bone-related
degradation products from C-terminal telopeptides of type 1
collagen) were measured by Rat-MID
TM Osteocalcin ELISA and
RatLaps
TM ELISA, respectively, from Nordic Bioscience Diag-
nostics A/S (Herlev Hovedgade 207, 2730 Herlev, Denmark).
Aglycones and conjugated serum isoflavones were extracted and
analyzed as previously described [18]. Briefly, aglycones were
measured directly by LC-MS, and conjugated isoflavones were
enzymatically deconjugated by incubating serum (100 ml) with a
mixture of sulfatase and glucuronidase (100 U Sulfatase H-5,
Sigma) and were measeured by LC-MS to obtain total isoflavones.
Samples were also incubated with b-glucuronidase (1000 U, B-1,
Sigma) to obtain the sum of glucuronidases and the aglycones.
Isoflavone sulfates were calculated by subtracting the glucuroni-
dase and aglycones from the total concentration.
Gene Microarray and Real-Time Reverse Transcription-
Polymerase Chain Reaction (Real-time RT-PCR)
After aspiration of bone marrow, right tibial bone total RNA
was extracted using TRI Reagent (MRC Inc., Cincinnati, OH)
according to the manufacturer’s recommendations followed by
DNase digestion and column cleanup using QIAGEN mini
columns. Three microarrays (GeneChip Rat 230 2.0; Affymetrix,
Santa Clara, CA) were used for each diet group; control, SPI, E2
and SPI plus E2 treated animals. Pools of equal amounts of RNA
from two to three rats were used for analyses per microarray,
representing at least eight rats per group over the three
microarrays. cRNA synthesis, labeling, hybridization, and scan-
ning were carried out using the manufacturer’s instructions and
Figure 4. Caveolin-1, membrane versus cytoplasm BMP-2 protein expression in bone of pre-pubertal female rats from Control,
standard casein diet group; E2, 10 mg/kg/d E2 treated group; SPI, soy protein isolate diet group; E2+SPI, combination of 10 mg/kg/d
E2 treated and SPI diet group. Quantitation of the intensity of the caveolin-1 bands in the autoradiograms was performed relative to expression
of b-actin, membrane BMP-2 (M-BMP-2) and nuclear BMP-2 (N-BMP-2) were performed relative to total BMP-2 (T-BMP-2). Data are Means 6 S.E.M,
n=3, with different letters differ significantly from each other at p,0.05, a,b,c.
doi:10.1371/journal.pone.0035736.g004
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were carried out using GeneSpring version 7.36software (Agilent
Technologies, Santa Clara, CA) [29]. The CEL files containing
probe level intensities were processed using the robust multiarray
analysis algorithm for background adjustment, normalization, and
log2 transformation of perfect match values [29]. Subsequently,
the data were subjected to normalization by setting measurements
less than 0.01 and by per-chip and per-gene normalization using
GeneSpring. The normalized data were used to generate a list of
differentially expressed genes among different diets with and
without E2. The detailed data has been deposited in a MIAME
compliant database (E.g. ArrayExpress, GEO), and it is available
to check on the MGED Society website with accession number
GSE30862 http://www.ncbi.nlm.nih.gov/geo/query/acc.
cgi?acc=GSE30862. Real-time RT-PCR was carried out using
SYBR Green and an ABI 7000 sequence detection system
(Applied Biosystems, Foster City, CA). Primers for rat and mouse
caveolin-1, ATF3, calcitonin and Runx2 were designed using
Primer Express software 2.0.0 (Applied Biosystems). Their
sequences are all listed in Table 2.
In vitro Osteoblast Differentiation Cell Culture
For in vitro cell culture experiments, bone marrow stromal cell
line ST2 cells were utilized and treated with serum from different
treatment groups. Cells were cultured in the plates in the presence
of minimal essential medium (Invitrogen, Calsbad, CA) with 10%
fetal bovine serum (FBS) (Hyclone Laboratories, Logan, UT) and
100 U/ml each of penicillin and streptomycin (Sigma-Aldrich).
When actual experiments were started, cells were cultured with
8% FBS without osteogenic medium as negative control. The
effects of treatment with 5% FBS plus either 2.0% 0.45 mm filtered
serum from control, SPI- or E2-treated rats or purified genistein
on ST2 cells were compared. Cell RNA and protein isolations and
real-time RT-PCR, western blotting were performed similarly
with the method described above.
Western Blotting
Right tibial bone tissue proteins for Western immunoblot
analysis were extracted using cell lysis buffer as described
previously [9]. Membrane and nuclear protein isolations were
performed according to procedures provided by manufacturer
(PIERCE Biotechnology). The phosphorylation status of ERK1/2
was examined by Western blotting using a mouse monoclonal
antibody recognizing tyrosine phosphorylated ERK1/2 or rabbit
polyclonal antibodies recognizing total ERK1/2 (Santa Cruz
Biotechnology) followed by incubation with either an anti-mouse
or an anti-rabbit antibody conjugated with horseradish peroxidase
(Santa Cruz Biotechnology). Similar Western blotting studies were
performed with antibodies to caveolin-1 (Santa Cruz Biotechnol-
ogy), BMP2 (Cell Signaling), Smad 4 and phospho-Smad 1/5/8
(Cell Signaling), and Runx 2 (Santa Cruz Biotechnology). Primary
antibodies were detected with a horseradish peroxidase-conjugat-
ed secondary antibody (Santa Cruz Biotechnology). Blots were
developed using chemiluminescence according to the manufac-
ture’s recommendations. Quantization of the intensity of the
Figure 5. Cell signaling transduction pathway after activation of BMP-2 by SPI and E2 in bone. (A), Protein was isolated from bone after
aspiration of bone marrow cells and performed Western blots. Smad and ERK1/2 phosphorylation and Runx2 protein expression in pre-pubertal
female rat bone from Control, standard casein diet group; E2, 10 mg/kg/d E2 treated group; SPI, soy protein isolate diet group; E2+SPI, combination of
10 mg/kg/d E2 treated and SPI diet group. Quantitation of the intensity of the phosphorylated bands of p-Smad1, 5, 8 and p-ERK1/2 in the
autoradiograms were performed relative to expression of total Smad4 and ERK1/2. Blot of Ponceau S staining showing protein loading control for
western blotting. (B), Showing real-time PCR analyses for Runx2. Data are Means 6 S.E.M, n=3, with different letters differ significantly from each
other at p,0.05, a,b,c.
doi:10.1371/journal.pone.0035736.g005
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TM
imaging system (Bio-Rad).
Data and Statistical Analyses
Data were expressed as mean 6 SEM One way analysis of
variance (ANOVA) was utilized to analyze diet effects and two-
way ANOVA for analysis of SPI, E2 interactions followed by
student Newman-Keuls post hoc analysis for multiple pair-wise
comparisons between treatment groups. Values were considered
statistically significant at p,0.05.
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Table 2. Real-Time Reverse-Transcription Polymerase Chain
Reaction (RT-PCR) Primer Sequences.
Gene Forward Primer Reverse Primer
Rat
Caveolin-1 GAGTCTGCCAAAGCAAGATTGCCA AGGCTTCGCAGCGTTACAGACTAT
RUNX2 CCGTGGCCTTCAAGGTTGTA ATTTCGTAGCTCGGCAGAGTAGTT
ATF-3 TTTCAAAGGGCGTAGGACTCCACA TTCAAATACCAGTCTCCACGGGCT
Calcitonin AGAAGAGATCCTGCAACACTGCCA GGCACAAAGTTGTCCTTCACCACA
Sost
(Sclerostin)
GGCAAGCCTTCAAGAATGATGCCA TGTACTCGGACACGTCTTTGGTGT
GAPDH TGAGGTGACCGCATCTTCTTG TGGTAACCAGGCGTCCGATA
Mouse
Caveolin-1 TGTACCGTGCATCAAGAGCTTCCT GTGCTGATGCGGATGTTGCTGAAT
RUNX2 CGGTCTCCTTCCAGGATGGT GCTTCCGTCAGCGTCAACA
GAPDH GTATGACTCCACTCACGGCAAA GGTCTCGCTCCTGGAAGATG
doi:10.1371/journal.pone.0035736.t002
Figure 6. SPI stimulates osteoblast differentiation via down-regulation of caveolin-1. ST2 cells were treated with 2% serum either from
control, 10 mg/kg/d E2 treated, SPI diet rats and 5 mM of purified genistein for 48 h. RNA and protein were collected. (A), Real-time PCR showing
relative caveolin-1 and Runx2 mRNA expression. Data are Means 6 SEM, triplicates, * p,0.05 versus control. (B), Western blotting showing caveolin-1
protein, nuclear SMD and cytosolic versus membrane BMP2 expression. Quantitation of the intensity of the caveolin-1 in the autoradiograms was
performed relative to expression of b-actin.
doi:10.1371/journal.pone.0035736.g006
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